FDA and CDC greenlight Pfizer COVID-19 vaccine for children ages 5 to 11
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., last night accepted the recommendation of her agency鈥檚 independent Advisory Committee on Immunization Practices to administer Pfizer鈥檚 pediatric COVID-19 vaccine to children between the ages of five and 11. Coupled with the Food and Drug Administration鈥檚 Oct. 29 emergency use authorization to Pfizer for its pediatric Covid-19 vaccine, this paves the way for the product鈥檚 administration to this age group immediately.
Related News Articles
Headline
Nearly 57% of mothers did not attend a postpartum follow-up visit three to eight weeks after giving birth, according to a report published July 29 by Cedar鈥
Headline
The Senate Appropriations Committee July 31 advanced the fiscal year 2026 appropriations bill for the Departments of Labor, Health and Human Services,鈥
Headline
The Joint Commission July 29 announced an initiative to address 鈥済aps鈥 in how children鈥檚 hospitals are accredited and certified. The program will remove or鈥
Headline
The AHA July 24 announced it is collaborating with health care technology leader Epic to help hospitals adopt tools that support the early detection and鈥
Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
A Health Affairs study on the decline of obstetric services in rural and urban hospitals nationwide from 2010-2022 found that seven states had at least 25% of鈥